Jennifer Kayden Lee, EVP, Head of North America at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 12,332 shares at $28.05 ($346K) on 2023-09-05, disclosed to the SEC on 2023-09-07.
Scheduled sale ($346k) by EVP, Head of North America under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.05 | 6,166 | $173K | 50.0% |
| 2 | $28.05 | 6,166 | $173K | 50.0% |
| Total | $28.05 avg | 12,332 | $346K | 100% |
| Filing → |
| RYTM | SELL | 2025-02-14 | $240K | — | Filing → |
| RYTM | SELL | 2025-02-11 | $611K | — | Filing → |
| RYTM | SELL | 2025-02-07 | $359K | — | Filing → |